Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAHUL NAVIN DOSHI

Allopathic & Osteopathic Physicians Internal Medicine Clinical Cardiac Electrophysiology

NPI
1710981766
CMS profile
32886
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$39,814.95

156 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAHUL NAVIN DOSHI

NPI 1710981766 · CMS profile ID 32886

Allopathic & Osteopathic Physicians / Internal Medicine / Clinical Cardiac Electrophysiology

LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1710981766?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAHUL NAVIN DOSHI, NPI 1710981766, CMS profile ID 32886. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1710981766?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). RAHUL NAVIN DOSHI, NPI 1710981766, CMS profile ID 32886. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1710981766?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
RAHUL NAVIN DOSHI, NPI 1710981766, CMS profile ID 32886, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 156 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1710981766?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

156 matching records · $39,814.95 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 156 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 156.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
CardioFocus, Inc. $101.6609/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853262199 CMS
Medtronic, Inc. $4.3309/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827305357 CMS
Abbott Laboratories $48.3109/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660609 CMS
Abbott Laboratories $91.0109/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660607 CMS
CARDIVA MEDICAL, INC. $43.5009/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839387273 CMS
CARDIVA MEDICAL, INC. $65.3309/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839387277 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,500.0009/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 770476752 CMS
Preventice Services, LLC $69.1409/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781054781 CMS
Impulse Dynamics (USA) Inc. $1,500.0008/31/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843143311 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $97.7408/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 768836502 CMS
Medtronic, Inc. $138.2308/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827305349 CMS
Abbott Laboratories $77.0608/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660599 CMS
Abbott Laboratories $159.2908/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660601 CMS
Abbott Laboratories $94.7608/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660619 CMS
BOSTON SCIENTIFIC CORPORATION $119.9508/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777546841 CMS
Medtronic, Inc. $118.1508/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827305343 CMS
Abbott Laboratories $168.2808/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660595 CMS
Abbott Laboratories $126.1308/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660597 CMS
BOSTON SCIENTIFIC CORPORATION $22.0407/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777546839 CMS
CARDIVA MEDICAL, INC. $125.0007/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839387309 CMS
Medtronic, Inc. $8.4507/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827305339 CMS
Abbott Laboratories $21.4207/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660591 CMS
Abbott Laboratories $21.5207/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660593 CMS
CARDIVA MEDICAL, INC. $62.0107/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839387307 CMS
Preventice Services, LLC $50.0007/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781054783 CMS
Preventice Services, LLC $500.0007/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781054789 CMS
Abbott Laboratories $2,231.2507/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660603 CMS
Abbott Laboratories $787.5007/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660605 CMS
Abbott Laboratories $13.5807/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660631 CMS
Abbott Laboratories $435.7507/21/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660625 CMS
Abbott Laboratories $232.2007/21/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660627 CMS
Abbott Laboratories $406.7007/21/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660629 CMS
BOSTON SCIENTIFIC CORPORATION $9.8607/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777546837 CMS
CARDIVA MEDICAL, INC. $48.5207/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839387305 CMS
CARDIVA MEDICAL, INC. $55.4007/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839387303 CMS
Abbott Laboratories $5.5807/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660623 CMS
Medtronic, Inc. $201.8207/07/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827305383 CMS
Abbott Laboratories $109.3007/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833660621 CMS
CVRx, Inc. $125.9707/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851086589 CMS
Abbott Laboratories $413.6806/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815583717 CMS
Abbott Laboratories $63.0006/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815576457 CMS
Abbott Laboratories $98.9206/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815576461 CMS
Preventice Services, LLC $13.6606/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781054775 CMS
Kiniksa Pharmaceuticals, Ltd. $16.2906/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852916759 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $94.8706/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 768836500 CMS
BOSTON SCIENTIFIC CORPORATION $9.2206/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777546835 CMS
Preventice Services, LLC $13.8306/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781054777 CMS
CardioFocus, Inc. $19.8905/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853262313 CMS
CardioFocus, Inc. $13.7205/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853262319 CMS
CardioFocus, Inc. $11.2505/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853262321 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $53,920.03 91
PY2020 $27,323.24 106
PY2021 $39,814.95 156
PY2022 $66,492.99 214
PY2023 $49,420.17 214
PY2024 $110,993.67 261
PY2025 $121,385.18 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $222,081.29 68
PY2024 Recipient $5,381.25 1
PY2024 Principal investigator $172,866.40 64
PY2023 Principal investigator $216,317.67 50
PY2022 Principal investigator $571,801.66 68
PY2021 Principal investigator $164,425.93 28
PY2020 Principal investigator $46,703.77 18
PY2019 Principal investigator $94,259.71 48

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

68 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $1,730.00 12/19/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166513
Principal investigator 1 Boston Scientific Corporation $879.48 12/09/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580584
Principal investigator 1 Impulse Dynamics (USA) Inc. $238.00 12/01/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121019
Principal investigator 1 Impulse Dynamics (USA) Inc. $5,250.00 12/01/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214121045
Principal investigator 1 Boston Scientific Corporation $44.26 11/25/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
MODULAR ATP No dispute reported 06/30/2026 1207580558
Principal investigator 1 Boston Scientific Corporation $2,913.04 11/25/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580582
Principal investigator 1 Janssen Research & Development, LLC $1,345.00 11/19/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166365
Principal investigator 1 Impulse Dynamics (USA) Inc. $350.00 11/13/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214121047
Principal investigator 1 Abbott Laboratories $2,576.00 11/12/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248159456
Principal investigator 1 Janssen Research & Development, LLC $1,368.00 11/07/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166269
Principal investigator 1 Janssen Research & Development, LLC $690.00 11/05/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166293
Principal investigator 1 Boston Scientific Corporation $260.00 10/28/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580580
Principal investigator 1 Abbott Laboratories $400.00 10/23/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248158540
Principal investigator 1 Impulse Dynamics (USA) Inc. $1,899.40 10/17/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121021
Principal investigator 1 Impulse Dynamics (USA) Inc. $973.00 10/17/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214121049
Principal investigator 1 Impulse Dynamics (USA) Inc. $975.00 10/17/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214121051
Principal investigator 1 Impulse Dynamics (USA) Inc. $1,200.00 10/17/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214121053
Principal investigator 1 Janssen Research & Development, LLC $1,101.00 10/17/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166371
Principal investigator 1 Janssen Research & Development, LLC $8,824.00 10/08/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166553
Principal investigator 1 Impulse Dynamics (USA) Inc. $210.00 10/01/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214120995
Principal investigator 1 Impulse Dynamics (USA) Inc. $210.00 10/01/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of Combined CCM and ICD Device in HFrEF (INTEGRA-D) No dispute reported 06/30/2026 1214121055
Principal investigator 1 CardioFocus, Inc. $6,950.20 09/26/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
POST APPROVAL STUDY OF HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILLATION No dispute reported 06/30/2026 1254949110
Principal investigator 1 Boston Scientific Corporation $1,081.92 09/16/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580578
Principal investigator 1 Impulse Dynamics (USA) Inc. $4,199.20 09/15/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121005
Principal investigator 1 Abbott Laboratories $792.00 08/28/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248156062
Principal investigator 1 Janssen Research & Development, LLC $3,607.00 08/25/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166308
Principal investigator 1 Abbott Laboratories $10,094.64 08/18/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248155558
Principal investigator 1 Impulse Dynamics (USA) Inc. $600.00 08/14/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214120997
Principal investigator 1 Impulse Dynamics (USA) Inc. $1,632.40 08/14/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121007
Principal investigator 1 Janssen Research & Development, LLC $3,886.00 08/11/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166486
Principal investigator 1 Janssen Research & Development, LLC $1,345.00 07/23/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166478
Principal investigator 1 Boston Scientific Corporation $1,961.40 07/22/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580576
Principal investigator 1 CardioFocus, Inc. $582.00 07/22/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
POST APPROVAL STUDY OF HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILLATION No dispute reported 06/30/2026 1254949108
Principal investigator 1 Impulse Dynamics (USA) Inc. $300.00 07/01/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214120999
Principal investigator 1 Impulse Dynamics (USA) Inc. $3,935.40 07/01/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121009
Principal investigator 1 Abbott Laboratories $7,028.00 06/23/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248151952
Principal investigator 1 Janssen Research & Development, LLC $1,345.00 06/23/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166334
Principal investigator 1 Janssen Research & Development, LLC $1,471.00 06/20/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166325
Principal investigator 1 Boston Scientific Corporation $5,610.90 06/17/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580574
Principal investigator 1 Boston Scientific Corporation $12,000.00 06/17/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
ADVENT PAS No dispute reported 06/30/2026 1207580594
Principal investigator 1 Abbott Laboratories $1,417.00 06/12/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248151810
Principal investigator 1 Impulse Dynamics (USA) Inc. $8,908.20 06/12/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121011
Principal investigator 1 Janssen Research & Development, LLC $629.00 06/09/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166279
Principal investigator 1 Boston Scientific Corporation $2,891.41 05/27/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580572
Principal investigator 1 Impulse Dynamics (USA) Inc. $238.00 05/14/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121013
Principal investigator 1 Abbott Laboratories $7,000.00 05/05/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248152658
Principal investigator 1 Janssen Research & Development, LLC $3,616.00 04/23/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166508
Principal investigator 1 Impulse Dynamics (USA) Inc. $2,500.00 04/15/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121001
Principal investigator 1 Boston Scientific Corporation $367.90 04/08/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580570
Principal investigator 1 Impulse Dynamics (USA) Inc. $210.00 03/26/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121003
Principal investigator 1 Impulse Dynamics (USA) Inc. $4,298.20 03/26/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121015
Principal investigator 1 Abbott Laboratories $792.00 03/13/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248147658
Principal investigator 1 Boston Scientific Corporation $520.00 03/11/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580566
Principal investigator 1 Boston Scientific Corporation $4,376.99 03/11/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580568
Principal investigator 1 Janssen Research & Development, LLC $8,495.00 02/19/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166316
Principal investigator 1 CardioFocus, Inc. $26,520.20 02/14/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
POST APPROVAL STUDY OF HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILLATION No dispute reported 06/30/2026 1254949106
Principal investigator 1 Abbott Laboratories $7,000.00 02/11/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248149184
Principal investigator 1 Boston Scientific Corporation $1,712.93 02/11/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580564
Principal investigator 1 Impulse Dynamics (USA) Inc. $488.00 01/30/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer) No dispute reported 06/30/2026 1214121017
Principal investigator 1 Abbott Laboratories $2,090.00 01/22/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248145050
Principal investigator 1 Janssen Research & Development, LLC $1,630.00 01/22/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175166358
Principal investigator 1 Abbott Laboratories $17.92 01/15/2025 Non-covered Recipient Entity
MPX Group
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248144660
Principal investigator 1 Boston Scientific Corporation $25,343.30 01/14/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580560
Principal investigator 1 Boston Scientific Corporation $2,755.00 01/14/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
CHAMPION-AF No dispute reported 06/30/2026 1207580562
Principal investigator 1 Abbott Laboratories $334.00 01/10/2025 Non-covered Recipient Entity
WCG Clinical, Inc
NCT05252702--Aveir DR i2i Study No dispute reported 06/30/2026 1248144662
Principal investigator 1 CardioFocus, Inc. $6,007.00 01/10/2025 Covered Recipient Teaching Hospital
Honorhealth Scottsdale Shea Med Ctr
POST APPROVAL STUDY OF HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILLATION No dispute reported 06/30/2026 1254949104
Principal investigator 1 Abbott Laboratories $15.00 01/06/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148054
Principal investigator 1 Abbott Laboratories $50.00 01/06/2025 Covered Recipient Teaching Hospital
Honorhealth John C. Lincoln Med Ctr
NCT06676072--A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: No dispute reported 06/30/2026 1248148056